SFX by Ex Libris Inc.

Title:	Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
Source:	Gene Therapy [0969-7128] Birkholz, K yr:2009

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Riddell, Stanley R. "Chimeric Antigen Receptor Modified T Cells - Clinical Translation in Stem Cell Transplantation and Beyond." Biology of blood and marrow transplantation 19.1 Suppl (2012): 2-5.
description	2.	Aronovich, Elena L. "The Sleeping Beauty transposon system - a non-viral vector for gene therapy." Human molecular genetics 20.R1 (2011): -20.
description	3.	Rasmussen, Anne-Marie M. "Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy." Journal of immunological methods 355.1-2 (2010): 52-60.
description	4.	Yoon, SH. "Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model." Cancer gene therapy 16.6 (2008): 489-97.
description	5.	June, Carl H. "Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia." The New England journal of medicine 365.8 (2011): 725-733.
description	6.	Grupp, Stephen A. "Adoptive Transfer of Autologous T cells Improves T Cell Repertoire Diversity and Long Term B cell Function in Pediatric Patients with Neuroblastoma." Clinical cancer research 18.24 (2012): 6732-41.
description	7.	Curran, Kevin J. "Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions." The journal of gene medicine 14.6 (2012): 405-415.
description	8.	Brown, Christine E. "Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells." Clinical cancer research 18.8 (2012): 2199-2209.
description	9.	Walchli, B. "A Practical Approach to T-Cell Receptor Cloning and Expression." PLoS ONE 6.11 (2011).
description	10.	Lanitis, E. "Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor." Molecular therapy 20.3 (2012): 633-633.
description	11.	Wilson, Matthew H. "Designing and testing chimeric zinc finger transposases." Methods in molecular biology (2010): 353-363.
description	12.	Wang, Jessie L-S e. "Delivery of siRNA Therapeutics: Barriers and Carriers." The AAPS journal 12.4 (2010): 492-503.
description	13.	Chailertvanitkul, Colin A. "Adenovirus: A blueprint for non-viral gene delivery." Current opinion in biotechnology 21.5 (2010): 627-632.
description	14.	Kochenderfer, James N. "Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor." Journal of immunotherapy 32.7 (2009): 689-702.
description	15.	Moore, C. "Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells." Transplantation proceedings 42.1 (2010): 371-375.
description	16.	Atkinson, H. "Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences." Genetica 138.5 (2010): 485-498.
description	17.	Hackett, Perry B. B. "Gene expression in Lung and Liver after Intravenous Infusion of Polyethyleneimine Complexes and Hydrodynamic Delivery of Sleeping Beauty Transposons." Human gene therapy 21.2 (2009): 210-220.
description	18.	Avalos, B R R. "The granulocyte colony-stimulating factor receptor and its role in disorders of granulopoiesis." Leukemia & lymphoma 28.3-4 (1998): 265-73.
description	19.	Kemp, M. "Quantitative network signal combinations downstream of TCR activation can predict IL-2 production response." The journal of immunology 178.8 (2007): 4984-4992.
description	20.	Stauss, Hans J J. "WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells." Blood cells, molecules & diseases 40.1 (2008): 113-6.